Luke Devey Vice President, Head of Translational Science, Immunology
Organisation: Janssen Pharmaceutical Companies of Johnson and Johnson
- Clinician Scientist Fellowship
Luke is Vice President, Head of Translational Science, Immunology at Janssen Pharmaceutical Companies of Johnson and Johnson.
After graduation from Oxford medical school, he trained in surgery and transplantation in South East Scotland and the West Midlands. Between 2004 and 2007 he undertook a PhD focusing on the role of hemeoxygnase-1 in liver transplantation.
He then progressed to an Academy of Medical Sciences/ Health Foundation Clinician Scientist Fellowship in Edinburgh (2009-13) before moving to GlaxoSmithKline to learn translational medicine and drug development.
In 2014 he relocated to Philadelphia to work on pre-clinical and clinical projects seeking to extend understanding of acute kidney injury and delayed graft function.
Luke's research relates to transplanted organs, specifically the role of antigen presenting cells and T regulatory cells in ischaemic preconditioning. He is interested in harnessing immune cells (specifically T regulatory cells) to overcome ischaemia reperfusion injury, which impacts upon the function of transplanted organs.